920
Participants
Start Date
February 21, 2017
Primary Completion Date
December 31, 2029
Study Completion Date
December 31, 2029
Glofitamab
Glofitamab will be administered at a dose and as per the schedule specified in the respective arms.
Obinutuzumab
Obinutuzumab 1000 mg single dose IV infusion on Day -7; or 2000 mg single dose administered on Day -7, or split into two 1000 mg doses administered on Days -1 and -7, and per the schedule specified in the respective arms.
Tocilizumab
Tocilizumab will be administered as an IV infusion, if required, for the management of severe Cytokine Release Syndrome (CRS) occurring during or after any infusion of glofitamab, as per the methods described in the Summary of Product Characteristics (SmPC) or other similar local prescribing documents.
ACTIVE_NOT_RECRUITING
National Taiwan Universtiy Hospital, Taipei
RECRUITING
China Medical University Hospital, Taichung
ACTIVE_NOT_RECRUITING
Auckland Cancer Trial Centre, Auckland
RECRUITING
Cliniques Universitaires St-Luc, Brussels
ACTIVE_NOT_RECRUITING
Prince of Wales Hospital, Randwick
RECRUITING
Rigshospitalet, København Ø
RECRUITING
Peter Maccallum Cancer Centre, Melbourne
RECRUITING
UZ Gent, Ghent
ACTIVE_NOT_RECRUITING
Mount Sinai Medical Center, New York
COMPLETED
MSKCC, New York
WITHDRAWN
A.O.U. Citta' Della Salute E Della Scienza-P.O. Molinette, Turin
ACTIVE_NOT_RECRUITING
Allegheny Health Network (Pittsburg PA), Pittsburgh
ACTIVE_NOT_RECRUITING
Istituto Clinico Humanitas, Rozzano
RECRUITING
Fond. IRCCS Istituto Nazionale Tumori, Milan
ACTIVE_NOT_RECRUITING
Hospital Univ. 12 de Octubre, Madrid
RECRUITING
CHU Saint Eloi, Montpellier
RECRUITING
CHU DE RENNES - CHU Pontchaillou, Rennes
ACTIVE_NOT_RECRUITING
Hospital Universitario Marques de Valdecilla, Santander
RECRUITING
AUSL della Romagna, Ravenna
RECRUITING
Hopital Claude Huriez, Lille
WITHDRAWN
Ingalls Memorial Hospital, Harvey
RECRUITING
Washington University, St Louis
RECRUITING
Ch Lyon Sud, Pierre-Bénite
WITHDRAWN
Hunstman Cancer Institute, Salt Lake City
RECRUITING
Hopital Henri Mondor, Créteil
ACTIVE_NOT_RECRUITING
Swedish Cancer Inst., Seattle
ACTIVE_NOT_RECRUITING
University of Michigan, Ann Arbor
ACTIVE_NOT_RECRUITING
Princess Margaret Cancer Center, Toronto
ACTIVE_NOT_RECRUITING
Vseobecna Fakultni Nemocnice v Praze, I. Interni Klinika - Klinika Hematoonkologie VFN a 1. LF UK, Prague
RECRUITING
Helsinki University Central Hospital, Helsinki
ACTIVE_NOT_RECRUITING
Uniwersyteckie Centrum Kliniczne, Gda?sk
RECRUITING
Uniwersytecki Szpital Kliniczny w Poznaniu, Późna
WITHDRAWN
Centrum Onkologii-Instytut im. M. Sklodowskiej-Curie, Warsaw
ACTIVE_NOT_RECRUITING
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wroclawiu, Wroc?aw
ACTIVE_NOT_RECRUITING
Hospital Universitari Germans Trias i Pujol, Badalona
ACTIVE_NOT_RECRUITING
Hospital Duran i Reynals L'Hospitalet, L'Hospitalet de Llobregat
ACTIVE_NOT_RECRUITING
Hospital del Mar, Barcelona
RECRUITING
Hospital Universitari Vall d'Hebron, Barcelona
Hoffmann-La Roche
INDUSTRY